DGAP-Adhoc: MeVis Medical Solutions AG: Raising forecast for the current fiscal year


MeVis Medical Solutions AG  / Key word(s): Change in Forecast

01.12.2014 18:11

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Bremen, December 1, 2014 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4],
a leading provider of medical imaging software, raises its forecast for the
present fiscal year due to the current business development:

  - For 2014 revenues are now expected to remain stable at between EUR 12.5
    and 13.0 million (previous forecast: slight decline in revenues to
    between EUR 12.0 and 12.5 million).

  - For the EBIT (earnings before interest and taxes), a slight decrease
    over the previous year continues to be expected, now at EUR 3.5 to 4.0
    million (previous forecast: EBIT between EUR 3.0 and 3.5 million).

  - For the end of 2014 another increase in liquidity is expected to now
    EUR 16.5 to 17.5 million due to a continued positive cash flow
    (previous forecast: EUR 15.0 to 16.0 million).


01.12.2014 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      MeVis Medical Solutions AG
              Caroline-Herschel-Str. 1
              28359 Bremen
              Germany
Phone:        +49 421 224 95 0
Fax:          +49 421 224 95 999
E-mail:       ir@mevis.de
Internet:     http://www.mevis.de
ISIN:         DE000A0LBFE4
WKN:          A0LBFE
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Düsseldorf, München, Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------